Cargando…

Growth hormone – insulin-like growth factor-I axis and bone mineral density in adults with thalassemia major

INTRODUCTION: Bone disease and short stature are frequent clinical features of patients with beta-thalassaemia major. Dysfunction of the GH-IGF-1 axis has been described in many thalassemics children and adolescents with short stature and reduced growth velocity. Assessment of the GH-IGF-1 axis in s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soliman, Ashraf, De Sanctis, Vincenzo, Yassin, Mohamed, Abdelrahman, Mohamed O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968729/ https://www.ncbi.nlm.nih.gov/pubmed/24701427 http://dx.doi.org/10.4103/2230-8210.126525

Ejemplares similares

Insulin-like growth factor- I and factors affecting it in thalassemia major
por: Soliman, Ashraf T., et al.
Publicado: (2015)

Growth and growth hormone - Insulin Like Growth Factor - I (GH-IGF-I) axis in chronic anemias
por: Ashraf, T. Soliman, et al.
Publicado: (2017)

Vitamin D Status in Thalassemia Major: an Update
por: Soliman, Ashraf, et al.
Publicado: (2013)

Insulin-like growth factor -1 (IGF-1) and glucose dysregulation in young adult patients with β-thalassemia major: causality or potential link?
por: De Sanctis, Vincenzo, et al.
Publicado: (2022)

The recommendation of the International Network of Clinicians for Endocrinopathies in Thalassemia and Adolescent Medicine for the assessment of growth hormone secretion in thalassemia
por: De Sanctis, Vincenzo, et al.
Publicado: (2015)

Effects of the anti-receptor activator of nuclear factor kappa B ligand denusomab on beta thalassemia major-induced osteoporosis
por: Yassin, Mohamed A., et al.
Publicado: (2014)

A Short Review on Growth and Endocrine Long-term Complications in Children and Adolescents with β-Thalassemia Major: Conventional Treatment versus Hematopoietic Stem Cell Transplantation
por: Ahmed, Shayma, et al.
Publicado: (2022)

Hypogonadism in male thalassemia major patients: pathophysiology, diagnosis and treatment
por: De Sanctis, Vincenzo, et al.
Publicado: (2018)

Final adult height and endocrine complications in young adults with β-thalassemia major (TM) who received oral iron chelation (OIC) in comparison with those who did not use OIC
por: Soliman, Ashraf T, et al.
Publicado: (2018)

The effects of excess weight on glucose homeostasis in young adult females with β-thalassemia major (β-TM): A preliminary retrospective study
por: De Sanctis, Vincenzo, et al.
Publicado: (2023)

Longitudinal Study on Liver Functions in Patients with Thalassemia Major before and after Deferasirox (DFX) Therapy
por: Soliman, Ashraf, et al.
Publicado: (2014)

Cortisol response to low dose versus standard dose (back-to-back) adrenocorticotrophic stimulation tests in children and young adults with thalassemia major
por: Soliman, Ashraf T., et al.
Publicado: (2013)

Longitudinal study on thyroid function in patients with thalassemia major: High incidence of central hypothyroidism by 18 years
por: Soliman, Ashraf T., et al.
Publicado: (2013)

Spinal cord compression secondary to extramedullary hematopoiesis: a rareness in a young adult with thalassemia major
por: Fareed, Shehab, et al.
Publicado: (2017)

Statural growth and prevalence of endocrinopathies in relation to liver iron content (LIC) in adult patients with beta thalassemia major (BTM) and sickle cell disease (SCD)
por: Yassin, Mohamed A, et al.
Publicado: (2018)

Detection of glycemic abnormalities in adolescents with beta thalassemia using continuous glucose monitoring and oral glucose tolerance in adolescents and young adults with β-thalassemia major: Pilot study
por: Soliman, Ashraf T., et al.
Publicado: (2013)

Evolution of combined impaired fasting glucose and impaired glucose tolerance in β-thalassemia major: Results in 58 patients with a mean 7.7- year follow-up
por: De Sanctis, Vincenzo, et al.
Publicado: (2022)

Nutritional studies in patients with β-thalassemia major: A short review
por: Soliman, Ashraf, et al.
Publicado: (2023)

Severe Liver Iron Concentrations (LIC) in 24 Patients with β-Thalassemia Major: Correlations with Serum Ferritin, Liver Enzymes and Endocrine Complications
por: Kanbour, Ibrahim, et al.
Publicado: (2018)

Does Insulin Like Growth Factor-1 (IGF-1) Deficiency Have a “Protective” Role in the Development of Diabetic Retinopathy in Thalassamia Major Patients?
por: De Sanctis, Vincenzo, et al.
Publicado: (2015)

Growth and endocrine disorders in thalassemia: The international network on endocrine complications in thalassemia (I-CET) position statement and guidelines
por: De Sanctis, Vincenzo, et al.
Publicado: (2013)

Final Height and Endocrine Complications in Patients with β-Thalassemia Intermedia: Our Experience in Non-Transfused Versus Infrequently Transfused Patients and Correlations with Liver Iron Content
por: Yassin, Mohamed A., et al.
Publicado: (2019)

Intravenous iron replacement therapy in eugonadal males with iron-deficiency anemia: Effects on pituitary gonadal axis and sperm parameters; A pilot study
por: Soliman, Ashraf, et al.
Publicado: (2014)

Insulin-like Growth Factor-1 (IGF-1): Demographic, Clinical and Laboratory Data in 120 Consecutive Adult Patients with Thalassaemia Major
por: De Sanctis, Vincenzo, et al.
Publicado: (2014)

Quality of life among adolescents aged 14 to 18 years with beta-thalassemia major (TM) in Qatar
por: Nashwan, Abdulqadir J., et al.
Publicado: (2018)

Spontaneous iliopsoas hematoma in a trasfusion dependent β-thalassemia patient with hypersplenism: a case report
por: Aishwariya, Padmakumari, et al.
Publicado: (2019)

Clinical characteristics, biochemical parameters and insulin response to oral glucose tolerance test (OGTT) in 25 transfusion dependent β-thalassemia (TDT) patients recently diagnosed with diabetes mellitus (DM)
por: de Sanctis, Vincenzo, et al.
Publicado: (2021)

Current practice in treating adult female thalassemia major patients with hypogonadism: An International Network of Clinicians for Endocrinopathies in Thalassemia and Adolescence Medicine survey from Italy
por: De Sanctis, Vincenzo, et al.
Publicado: (2016)

Late-onset Male Hypogonadism and Fertility Potential in Thalassemia Major Patients: Two Emerging Issues
por: De Sanctis, Vincenzo, et al.
Publicado: (2015)

Chronic inflammation and the growth hormone/insulin-like growth factor-1 axis
por: Witkowska-Sędek, Ewelina, et al.
Publicado: (2021)

Retrospective study on long-term effects of hormone replacement therapy (HRT) and iron chelation therapy on glucose homeostasis and insulin secretion in female ß- thalassemia major (β-TM) patients with acquired hypogonadotropic- hypogonadism (AHH)
por: De Sanctis, Vincenzo, et al.
Publicado: (2023)

The growth hormone–insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders
por: Blum, Werner F, et al.
Publicado: (2018)

Association Between the Growth Hormone/Insulin-Like Growth Factor-1 Axis and Muscle Density in Children and Adolescents of Short Stature
por: Yang, Guangzhi, et al.
Publicado: (2022)

The Frequency of Adrenal Insufficiency in Adolescents and Young Adults with Thalassemia Major versus Thalassemia Intermedia in Iran
por: Matin, Sara, et al.
Publicado: (2015)

Longitudinal study of ICET-A on glucose tolerance, insulin sensitivity and β-cell secretion in eleven β-thalassemia major patients with mild iron overload
por: De Sanctis, Vincenzo, et al.
Publicado: (2023)

Does blood transfusion affect pituitary gonadal axis and sperm parameters in young males with sickle cell disease?
por: Soliman, Ashraf T., et al.
Publicado: (2013)

Bone Mineral Density in Thalassemia Major Patients from Antalya, Turkey
por: Aslan, Ibrahim, et al.
Publicado: (2012)

Comparison of Bone Mineral Density in Thalassemia Major Patients with Healthy Controls
por: Meena, Mahesh Chand, et al.
Publicado: (2015)

PSUN314 Severe Insulin Resistance Impacts the Growth Hormone-Insulin-Like Growth Factor-I Axis and Linear Growth
por: Okawa, Marinna
Publicado: (2022)

Growth and Endocrine Function in Tunisian Thalassemia Major Patients
por: Dhouib, Naouel Guirat, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v4le8huq5m7m4j44a16tkgpe5d